As more Asia biotechs turn to regenerative medicine to address disorders without a cure, Medipost Inc. is continuing global expansion with Cartistem, its allogeneic human umbilical cord blood-derived ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...